OBIO ▼ -11.0% - Orchestra BioMed Holdings, Inc. $OBIO Orchestra BioMed — Prices $75M public offering of 15M shares at $5.00 per share — Underwriters hold a 30-day option for 2.25M more shares — Funds the BACKBEAT hypertension pivotal trial with Medtronic and the Virtue SAB program 06-NOV-2026 05:19 AM ET